| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | Chief Commercial Officer | Common Stock | 0 | $20.00 | Mar 2, 2023 | Direct | |
| OPIANT PHARMACEUTICALS, INC. | Chief Commercial Officer | Stock Option (right to buy) | 0 | $10.00 | Mar 2, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OPNT | OPIANT PHARMACEUTICALS, INC. | Mar 2, 2023 | 5 | -$638K | 4 | Mar 3, 2023 | Chief Commercial Officer |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Jul 20, 2022 | 1 | -$11.5K | 4 | Jul 21, 2022 | Chief Commercial Officer |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Jun 27, 2022 | 1 | $0 | 4 | Jun 29, 2022 | Chief Commercial Officer |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Jan 4, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Chief Commercial Officer |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Aug 31, 2021 | 1 | $34.7K | 4 | Sep 1, 2021 | Chief Commercial Officer |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Jul 19, 2021 | 2 | $0 | 4 | Jul 20, 2021 | Chief Commercial Officer |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Jul 19, 2021 | 0 | $0 | 3 | Jul 20, 2021 | Chief Commercial Officer |